( in Million)
Particulars
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Audited / UnAudited
UnAudited
UnAudited
UnAudited
UnAudited
Net Sales
814.09
755.76
1421.48
740.84
Total Expenditure
697.59
690.89
1212.69
645.23
PBIDT (Excl OI)
116.5
64.87
208.79
95.61
Other Income
4.34
230.68
58.88
5.09
Operating Profit
120.84
295.55
267.67
100.69
Interest
9.13
7.26
10.24
11.12
Exceptional Items
NA
-12
-40
NA
PBDT
111.71
276.29
217.43
89.56
Depreciation
30.2
29.26
29.16
29.31
Profit Before Tax
81.50
247.03
188.27
60.25
Provisions and contingencies
NA
NA
NA
NA
Profit After Tax
60.87
178.01
153.6
37.45
Extraordinary Items
NA
NA
NA
NA
Prior Period Expenses
NA
NA
NA
NA
Other Adjustments
NA
NA
NA
NA
Net Profit
60.87
178.01
153.6
37.45
Minority Interest
-0.1
0.14
-0.09
-0.1
Shares of Associates
-0.04
-0.03
Misc. Expenses Written off
NA
NA
NA
NA
Consolidated Net Profit
60.79
178.11
153.48
37.37
Equity Capital
107.52
107.52
107.52
107.52
Calculated EPS
1.13
3.31
2.85
0.69
Calculated EPS (Annualised)
4.52
13.25
11.41
2.78
No of Public Share Holdings
31539460
31539460
31539460
31539460
% of Public Share Holdings
58.67
58.67
58.67
58.67
PBIDTM% (Excl OI)
14.31
8.58
14.68
12.90
PBIDTM%
14.84
39.10
18.83
13.59
PBDTM%
13.72
36.55
15.29
12.09